Skip to main content

Jay Johnston, Gerard Vaillant, Laurence, Thomas Caskey, Hirsch, Betty Woods, John Wareham, Terrie Pizzie, Mathias Uhln

Premium

Jay Johnston and Gerard Vaillant have joined the board of directors of Luminex, the Austin, Texas-based company said last week. Laurence Hirsch and Thomas Caskey will retire from the board before the summer.

Johnston is chairman of QuesTek Innovations. In the past, he was corporate vice president for diagnostic assays and systems at Abbott Laboratories. He holds an MBA in general management from Amos Tuck School of Business Administration and an AB degree in public administration from Dartmouth College.

Until he retired last year, Vaillant was company group chairman of Johnson & Johnson. He holds a master’s degree and superior certificate in biochemistry and industrial chemistry from Paris University of Sciences and a degree in marketing from Ecole Superieure de Commerce de Paris.


Betty Woods has been named non-executive chairman of the board of directors for Beckman Coulter, effective April 7 at the company’s stockholder’s meeting. She will succeed John Wareham, who is retiring, the company said this month. Woods is the former president and CEO of Premera Blue Cross (formerly Blue Cross of Washington and Alaska) and chief executive officer of Premara, the holding company of Premera Blue Cross.


Terrie Pizzie will become senior vice president of commercial operations at Biacore International starting March 1, the company said this week. Prior to joining the company, he was vice president Europe of Applied Biosystems. Before that, he was ABI’s director of sales and marketing in Europe.


Mathias Uhlén will receive this year’s Akzo Nobel science award on March 15, the Netherlands-based company said yesterday. He is a professor at the Royal Institute of Technology in Stockholm, Sweden.

Uhlen is the initiator of a project at his institute to map 22,000 human proteins. He is also the founder of a number of biotechnology companies, including Pyrosequencing, Affibody, Creative Peptides, SweTree Genomics, and Visual Bioinformatics.

 

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.